Donald Bergstrom, M.D., Ph.D.

Donald Bergstrom, M.D., Ph.D.

President, Research & DevelopmentatRelay Therapeutics· In proxies 2021–2025

Pay in FY2025-68% from the year before · Relay Therapeutics stock +105.3% the same year

Donald Bergstrom, M.D., Ph.D. was paid $2.1M in FY2025 (Dec), down 68%. Relay Therapeutics stock rose 105.3% that year.

Pay$100 in the stock at the end of FY20 → $20
Pay is from the Summary Compensation Table of each Relay Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Relay TherapeuticsPublic company · 5 yr
    • President, Research & Development2021 – Present · 5 yrStock in role -58%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?